Proton therapy systems offer the basic advantage of targeting the tumors precisely along with reduction of risk of the side-effects. Plus, no harm is caused to the healthy tissues. Dose could also be escalated as peer requirement. On these grounds, proton therapy centers are getting set up all over the world. The National Association for Proton Therapy (NAPT) is into spreading awareness regarding proton therapy’s clinical advantages. As such, proton therapy systems are bound to grow without any barriers in the upcoming period.
Application-wise, the proton therapy systems market spans gastrointestinal, lymphomas, pediatric, prostate, and brain cancers.
The trend of medical tourism is also fostering the development of prostate therapy systems market. This scenario is expected to continue on healthy grounds in the years to come. The developing economies of the LATAM, MEA, and Asia-Pacific are expected to turn the proton therapy systems market in their favour going forward. The market dynamics would take a 180 degree turn, with the developed economies going steady and developing economies being ever-ready for accommodating the novelties.
Coming to Market Suspension
The proton therapy systems market, by product, is inclusive of services and equipment. By type, it says multi-room systems and single-room systems. Furthermore, the vein disorders like deep vein thrombosis, lymphedema, leg ulcers, blood clots, and varicose veins are treated with compression therapy. The products falling in the category of compression therapy products include stockings and bandages.
In May 2020, AIROS, did come up with its AIROS 6 Sequential Compression Therapy device approved by the US FDA, along with Arm Plus garments for treating lymphedema in back, arm, shoulder, and chest. Likewise, April 2018 saw Sigvaris AG launching SAMSON stockings’ updated version. They are made from skin-friendly cotton that keep moisture at bay.
North America holds the largest market share due to growing occurrences of cancers. Also, there are several well-established “proton therapy centers” present all through the US. Also, the major players are into development of numerous advanced particle therapy systems for treating such fatal disorders. Europe comes in second over here. The Asia-Pacific is expected to grow at the highest rate between 2020 and 2030 with foreign investors investing aggressively in the emerging markets like India and China.
The key market participants include Mevion Medical Systems, IBA, Optivus Proton Therapy, Inc., ProNova Solutions LLC, Varian Medical Systems, Advanced Oncotherapy plc, Sumitomo Heavy Industries, Ltd., Hitachi, Ltd., and ProTom International.
Regarding developments, Philips and IBA, in June 2017, did collaborate for expansion of their business in the emerging economies of India and Brazil. PRONOVA SC360 from ProNova holds the distinction of maintaining a 360 degree treatment angle along with completely accessible treatment isocenter, thereby making way for stellar performance.
With ever-increasing incidences of various types of cancers, the proton therapy systems market is expected to grow unabated between 2020 and 2030. Out of these, pediatric cancer is expected to take the centre-stage, more so due to people opting for early diagnoses herein.